180 related articles for article (PubMed ID: 20379755)
1. Computational characterization of how the VX nerve agent binds human serum paraoxonase 1.
Fairchild SZ; Peterson MW; Hamza A; Zhan CG; Cerasoli DM; Chang WE
J Mol Model; 2011 Jan; 17(1):97-109. PubMed ID: 20379755
[TBL] [Abstract][Full Text] [Related]
2. VX hydrolysis by human serum paraoxonase 1: a comparison of experimental and computational results.
Peterson MW; Fairchild SZ; Otto TC; Mohtashemi M; Cerasoli DM; Chang WE
PLoS One; 2011; 6(5):e20335. PubMed ID: 21655255
[TBL] [Abstract][Full Text] [Related]
3. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.
Otto TC; Harsch CK; Yeung DT; Magliery TJ; Cerasoli DM; Lenz DE
Biochemistry; 2009 Nov; 48(43):10416-22. PubMed ID: 19764813
[TBL] [Abstract][Full Text] [Related]
4. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
5. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
[TBL] [Abstract][Full Text] [Related]
6. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.
Yeung DT; Josse D; Nicholson JD; Khanal A; McAndrew CW; Bahnson BJ; Lenz DE; Cerasoli DM
Biochim Biophys Acta; 2004 Oct; 1702(1):67-77. PubMed ID: 15450851
[TBL] [Abstract][Full Text] [Related]
7. In silico analyses of substrate interactions with human serum paraoxonase 1.
Hu X; Jiang X; Lenz DE; Cerasoli DM; Wallqvist A
Proteins; 2009 May; 75(2):486-98. PubMed ID: 18951406
[TBL] [Abstract][Full Text] [Related]
8. Rational design of organophosphorus hydrolase with high catalytic efficiency for detoxifying a V-type nerve agent.
Jeong YS; Choi JM; Kyeong HH; Choi JY; Kim EJ; Kim HS
Biochem Biophys Res Commun; 2014 Jul; 449(3):263-7. PubMed ID: 24824182
[TBL] [Abstract][Full Text] [Related]
9. Balancing the stability and the catalytic specificities of OP hydrolases with enhanced V-agent activities.
Reeves TE; Wales ME; Grimsley JK; Li P; Cerasoli DM; Wild JR
Protein Eng Des Sel; 2008 Jun; 21(6):405-12. PubMed ID: 18434422
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae.
Otto TC; Kasten SA; Kovaleva E; Liu Z; Buchman G; Tolosa M; Davis D; Smith JR; Balcerzak R; Lenz DE; Cerasoli DM
Chem Biol Interact; 2010 Sep; 187(1-3):388-92. PubMed ID: 20176005
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic hydrolysis of Russian-VX by organophosphorus hydrolase.
Rastogi VK; DeFrank JJ; Cheng TC; Wild JR
Biochem Biophys Res Commun; 1997 Dec; 241(2):294-6. PubMed ID: 9425265
[TBL] [Abstract][Full Text] [Related]
12. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates.
Yeung DT; Lenz DE; Cerasoli DM
FEBS J; 2005 May; 272(9):2225-30. PubMed ID: 15853807
[TBL] [Abstract][Full Text] [Related]
13. Engineering the Organophosphorus Acid Anhydrolase Enzyme for Increased Catalytic Efficiency and Broadened Stereospecificity on Russian VX.
Daczkowski CM; Pegan SD; Harvey SP
Biochemistry; 2015 Oct; 54(41):6423-33. PubMed ID: 26418828
[TBL] [Abstract][Full Text] [Related]
14. Molecular binding scaffolds increase local substrate concentration enhancing the enzymatic hydrolysis of VX nerve agent.
Lang X; Hong X; Baker CA; Otto TC; Wheeldon I
Biotechnol Bioeng; 2020 Jul; 117(7):1970-1978. PubMed ID: 32239488
[TBL] [Abstract][Full Text] [Related]
15. Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1.
Saleem A; Azam SS; Zarina S
Eur Biophys J; 2012 Feb; 41(2):241-8. PubMed ID: 22193970
[TBL] [Abstract][Full Text] [Related]
16. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents.
Bigley AN; Raushel FM
Chem Biol Interact; 2019 Aug; 308():80-88. PubMed ID: 31100274
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.
Bigley AN; Xu C; Henderson TJ; Harvey SP; Raushel FM
J Am Chem Soc; 2013 Jul; 135(28):10426-32. PubMed ID: 23789980
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanic study of nerve agent O-ethyl S-[2-(diisopropylamino)ethyl]methylphosphonothioate (VX) bound to the active site of Torpedo californica acetylcholinesterase.
Albaret C; Lacoutière S; Ashman WP; Froment D; Fortier PL
Proteins; 1997 Aug; 28(4):543-55. PubMed ID: 9261870
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis of organophosphorus hydrolase to enhance hydrolysis of the nerve agent VX.
Gopal S; Rastogi V; Ashman W; Mulbry W
Biochem Biophys Res Commun; 2000 Dec; 279(2):516-9. PubMed ID: 11118318
[TBL] [Abstract][Full Text] [Related]
20. QM/MM and MM MD simulations on decontamination of the V-type nerve agent VX by phosphotriesterase: toward a comprehensive understanding of steroselectivity and activity.
Fan F; Zheng Y; Fu Y; Zhang Y; Zheng H; Lyu C; Chen L; Huang J; Cao Z
Phys Chem Chem Phys; 2022 May; 24(18):10933-10943. PubMed ID: 35466335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
